Announcing Research 101 | UMR Answers Common Questions About NIH Research in this New Fact Sheet Series
Why Invest in NIH Research? | UMR Offers Fact Sheets Explaining Why Congress Must #keepNIHstrong
Read UMR's Statement on the House Appropriations Committee's Passage of FY23 Labor-HHS Funding Bill
NIH's Role In Sustaining the U.S. Economy | 2022 Update Now Available

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

BU NEIDL’s COVID-19 Work the Subject of a New Yorker Profile

In a feature published Thursday on The New Yorker website, staff writer and physician Jerome Groopman profiles the painstaking research on COVID-19 at Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL) and how its scientists are meticulously working to develop a vaccine for the virus that has claimed the lives of more than 630,000 people worldwide. In the piece, titled “The Long Game of Coronavirus Research,” Groopman argues that while fast-developed vaccines make headlines, more calculated work is just as critical.